Comments
Shire's ADHD amphetamine wins British backing
19.12.2012. | LONDON (Reuters) - Shire's hyperactivity treatment Vyvanse will be available in Europe within months after Britain's drugs regulator backed the amphetamine-based stimulant used to treat millions of U.S. students....
